ICD-10-PCS FY2025 code changes

ICD-10-PCS update effective October 1, 2024: 371 new codes, 61 deleted, 0 revised titles. Compared with FY2024 (April 1, 2024). Source: the official CMS order files.

Other ICD-10-PCS releases: FY2027, FY2026 (April 1, 2026), FY2026, FY2025 (April 1, 2025), FY2024 (April 1, 2024), FY2024, FY2023 (April 1, 2023), FY2023, FY2022 (April 1, 2022), FY2022, FY2021 (January 1, 2021), FY2021, FY2020 (August 1, 2020), FY2020, FY2019, FY2018, FY2017.

Also in this release: ICD-10-CM changes.

New codes (371)

• 00503Z4 Destruction of Brain using Stereoelectroencephalographic Radiofrequency Ablation, Percutaneous Approach
• 00K0XZ1 Map Brain using Connectomic Analysis, External Approach
• 041309R Bypass Hepatic Artery to Lower Artery with Autologous Venous Tissue, Open Approach
• 04130AR Bypass Hepatic Artery to Lower Artery with Autologous Arterial Tissue, Open Approach
• 04130JR Bypass Hepatic Artery to Lower Artery with Synthetic Substitute, Open Approach
• 04130KR Bypass Hepatic Artery to Lower Artery with Nonautologous Tissue Substitute, Open Approach
• 04130ZR Bypass Hepatic Artery to Lower Artery, Open Approach
• 041349R Bypass Hepatic Artery to Lower Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach
• 04134AR Bypass Hepatic Artery to Lower Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
• 04134JR Bypass Hepatic Artery to Lower Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
• 04134KR Bypass Hepatic Artery to Lower Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
• 04134ZR Bypass Hepatic Artery to Lower Artery, Percutaneous Endoscopic Approach
• 041409R Bypass Splenic Artery to Lower Artery with Autologous Venous Tissue, Open Approach
• 04140AR Bypass Splenic Artery to Lower Artery with Autologous Arterial Tissue, Open Approach
• 04140JR Bypass Splenic Artery to Lower Artery with Synthetic Substitute, Open Approach
• 04140KR Bypass Splenic Artery to Lower Artery with Nonautologous Tissue Substitute, Open Approach
• 04140ZR Bypass Splenic Artery to Lower Artery, Open Approach
• 041449R Bypass Splenic Artery to Lower Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach
• 04144AR Bypass Splenic Artery to Lower Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
• 04144JR Bypass Splenic Artery to Lower Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
• 04144KR Bypass Splenic Artery to Lower Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
• 04144ZR Bypass Splenic Artery to Lower Artery, Percutaneous Endoscopic Approach
• 047K342 Dilation of Right Femoral Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach
• 047K352 Dilation of Right Femoral Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047K362 Dilation of Right Femoral Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047K372 Dilation of Right Femoral Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047L342 Dilation of Left Femoral Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach
• 047L352 Dilation of Left Femoral Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047L362 Dilation of Left Femoral Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047L372 Dilation of Left Femoral Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047M342 Dilation of Right Popliteal Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach
• 047M352 Dilation of Right Popliteal Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047M362 Dilation of Right Popliteal Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047M372 Dilation of Right Popliteal Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047N342 Dilation of Left Popliteal Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach
• 047N352 Dilation of Left Popliteal Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047N362 Dilation of Left Popliteal Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047N372 Dilation of Left Popliteal Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047P342 Dilation of Right Anterior Tibial Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach
• 047P352 Dilation of Right Anterior Tibial Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047P362 Dilation of Right Anterior Tibial Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047P372 Dilation of Right Anterior Tibial Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047Q342 Dilation of Left Anterior Tibial Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach
• 047Q352 Dilation of Left Anterior Tibial Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047Q362 Dilation of Left Anterior Tibial Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047Q372 Dilation of Left Anterior Tibial Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047R342 Dilation of Right Posterior Tibial Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach
• 047R352 Dilation of Right Posterior Tibial Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047R362 Dilation of Right Posterior Tibial Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047R372 Dilation of Right Posterior Tibial Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047S342 Dilation of Left Posterior Tibial Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach
• 047S352 Dilation of Left Posterior Tibial Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047S362 Dilation of Left Posterior Tibial Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047S372 Dilation of Left Posterior Tibial Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047T342 Dilation of Right Peroneal Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach
• 047T352 Dilation of Right Peroneal Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047T362 Dilation of Right Peroneal Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047T372 Dilation of Right Peroneal Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047U342 Dilation of Left Peroneal Artery with Drug-eluting Intraluminal Device, Sustained Release, Percutaneous Approach
• 047U352 Dilation of Left Peroneal Artery with Two Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047U362 Dilation of Left Peroneal Artery with Three Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 047U372 Dilation of Left Peroneal Artery with Four or More Drug-eluting Intraluminal Devices, Sustained Release, Percutaneous Approach
• 07100Z3 Bypass Head Lymphatic to Peripheral Vein, Open Approach
• 07100Z4 Bypass Head Lymphatic to Central Vein, Open Approach
• 07100Z7 Bypass Head Lymphatic to Lymphatic, Open Approach
• 07100ZK Bypass Head Lymphatic to Thoracic Duct, Open Approach
• 07100ZL Bypass Head Lymphatic to Cisterna Chyli, Open Approach
• 07104Z3 Bypass Head Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
• 07104Z4 Bypass Head Lymphatic to Central Vein, Percutaneous Endoscopic Approach
• 07104Z7 Bypass Head Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
• 07104ZK Bypass Head Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
• 07104ZL Bypass Head Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
• 07110Z3 Bypass Right Neck Lymphatic to Peripheral Vein, Open Approach
• 07110Z4 Bypass Right Neck Lymphatic to Central Vein, Open Approach
• 07110Z7 Bypass Right Neck Lymphatic to Lymphatic, Open Approach
• 07110ZK Bypass Right Neck Lymphatic to Thoracic Duct, Open Approach
• 07110ZL Bypass Right Neck Lymphatic to Cisterna Chyli, Open Approach
• 07114Z3 Bypass Right Neck Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
• 07114Z4 Bypass Right Neck Lymphatic to Central Vein, Percutaneous Endoscopic Approach
• 07114Z7 Bypass Right Neck Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
• 07114ZK Bypass Right Neck Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
• 07114ZL Bypass Right Neck Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
• 07120Z3 Bypass Left Neck Lymphatic to Peripheral Vein, Open Approach
• 07120Z4 Bypass Left Neck Lymphatic to Central Vein, Open Approach
• 07120Z7 Bypass Left Neck Lymphatic to Lymphatic, Open Approach
• 07120ZK Bypass Left Neck Lymphatic to Thoracic Duct, Open Approach
• 07120ZL Bypass Left Neck Lymphatic to Cisterna Chyli, Open Approach
• 07124Z3 Bypass Left Neck Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
• 07124Z4 Bypass Left Neck Lymphatic to Central Vein, Percutaneous Endoscopic Approach
• 07124Z7 Bypass Left Neck Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
• 07124ZK Bypass Left Neck Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
• 07124ZL Bypass Left Neck Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
• 07130Z3 Bypass Right Upper Extremity Lymphatic to Peripheral Vein, Open Approach
• 07130Z4 Bypass Right Upper Extremity Lymphatic to Central Vein, Open Approach
• 07130Z7 Bypass Right Upper Extremity Lymphatic to Lymphatic, Open Approach
• 07130ZK Bypass Right Upper Extremity Lymphatic to Thoracic Duct, Open Approach
• 07130ZL Bypass Right Upper Extremity Lymphatic to Cisterna Chyli, Open Approach
• 07134Z3 Bypass Right Upper Extremity Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
• 07134Z4 Bypass Right Upper Extremity Lymphatic to Central Vein, Percutaneous Endoscopic Approach
• 07134Z7 Bypass Right Upper Extremity Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
• 07134ZK Bypass Right Upper Extremity Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
• 07134ZL Bypass Right Upper Extremity Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
• 07140Z3 Bypass Left Upper Extremity Lymphatic to Peripheral Vein, Open Approach
• 07140Z4 Bypass Left Upper Extremity Lymphatic to Central Vein, Open Approach
• 07140Z7 Bypass Left Upper Extremity Lymphatic to Lymphatic, Open Approach
• 07140ZK Bypass Left Upper Extremity Lymphatic to Thoracic Duct, Open Approach
• 07140ZL Bypass Left Upper Extremity Lymphatic to Cisterna Chyli, Open Approach
• 07144Z3 Bypass Left Upper Extremity Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
• 07144Z4 Bypass Left Upper Extremity Lymphatic to Central Vein, Percutaneous Endoscopic Approach
• 07144Z7 Bypass Left Upper Extremity Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
• 07144ZK Bypass Left Upper Extremity Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
• 07144ZL Bypass Left Upper Extremity Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
• 07150Z3 Bypass Right Axillary Lymphatic to Peripheral Vein, Open Approach
• 07150Z4 Bypass Right Axillary Lymphatic to Central Vein, Open Approach
• 07150Z7 Bypass Right Axillary Lymphatic to Lymphatic, Open Approach
• 07150ZK Bypass Right Axillary Lymphatic to Thoracic Duct, Open Approach
• 07150ZL Bypass Right Axillary Lymphatic to Cisterna Chyli, Open Approach
• 07154Z3 Bypass Right Axillary Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
• 07154Z4 Bypass Right Axillary Lymphatic to Central Vein, Percutaneous Endoscopic Approach
• 07154Z7 Bypass Right Axillary Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
• 07154ZK Bypass Right Axillary Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
• 07154ZL Bypass Right Axillary Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
• 07160Z3 Bypass Left Axillary Lymphatic to Peripheral Vein, Open Approach
• 07160Z4 Bypass Left Axillary Lymphatic to Central Vein, Open Approach
• 07160Z7 Bypass Left Axillary Lymphatic to Lymphatic, Open Approach
• 07160ZK Bypass Left Axillary Lymphatic to Thoracic Duct, Open Approach
• 07160ZL Bypass Left Axillary Lymphatic to Cisterna Chyli, Open Approach
• 07164Z3 Bypass Left Axillary Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
• 07164Z4 Bypass Left Axillary Lymphatic to Central Vein, Percutaneous Endoscopic Approach
• 07164Z7 Bypass Left Axillary Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
• 07164ZK Bypass Left Axillary Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
• 07164ZL Bypass Left Axillary Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
• 07170Z3 Bypass Thorax Lymphatic to Peripheral Vein, Open Approach
• 07170Z4 Bypass Thorax Lymphatic to Central Vein, Open Approach
• 07170Z7 Bypass Thorax Lymphatic to Lymphatic, Open Approach
• 07170ZK Bypass Thorax Lymphatic to Thoracic Duct, Open Approach
• 07170ZL Bypass Thorax Lymphatic to Cisterna Chyli, Open Approach
• 07174Z3 Bypass Thorax Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
• 07174Z4 Bypass Thorax Lymphatic to Central Vein, Percutaneous Endoscopic Approach
• 07174Z7 Bypass Thorax Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
• 07174ZK Bypass Thorax Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
• 07174ZL Bypass Thorax Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
• 07180Z3 Bypass Right Internal Mammary Lymphatic to Peripheral Vein, Open Approach
• 07180Z4 Bypass Right Internal Mammary Lymphatic to Central Vein, Open Approach
• 07180Z7 Bypass Right Internal Mammary Lymphatic to Lymphatic, Open Approach
• 07180ZK Bypass Right Internal Mammary Lymphatic to Thoracic Duct, Open Approach
• 07180ZL Bypass Right Internal Mammary Lymphatic to Cisterna Chyli, Open Approach
• 07184Z3 Bypass Right Internal Mammary Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
• 07184Z4 Bypass Right Internal Mammary Lymphatic to Central Vein, Percutaneous Endoscopic Approach
• 07184Z7 Bypass Right Internal Mammary Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
• 07184ZK Bypass Right Internal Mammary Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
• 07184ZL Bypass Right Internal Mammary Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
• 07190Z3 Bypass Left Internal Mammary Lymphatic to Peripheral Vein, Open Approach
• 07190Z4 Bypass Left Internal Mammary Lymphatic to Central Vein, Open Approach
• 07190Z7 Bypass Left Internal Mammary Lymphatic to Lymphatic, Open Approach
• 07190ZK Bypass Left Internal Mammary Lymphatic to Thoracic Duct, Open Approach
• 07190ZL Bypass Left Internal Mammary Lymphatic to Cisterna Chyli, Open Approach
• 07194Z3 Bypass Left Internal Mammary Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
• 07194Z4 Bypass Left Internal Mammary Lymphatic to Central Vein, Percutaneous Endoscopic Approach
• 07194Z7 Bypass Left Internal Mammary Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
• 07194ZK Bypass Left Internal Mammary Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
• 07194ZL Bypass Left Internal Mammary Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
• 071B0Z3 Bypass Mesenteric Lymphatic to Peripheral Vein, Open Approach
• 071B0Z4 Bypass Mesenteric Lymphatic to Central Vein, Open Approach
• 071B0Z7 Bypass Mesenteric Lymphatic to Lymphatic, Open Approach
• 071B0ZK Bypass Mesenteric Lymphatic to Thoracic Duct, Open Approach
• 071B0ZL Bypass Mesenteric Lymphatic to Cisterna Chyli, Open Approach
• 071B4Z3 Bypass Mesenteric Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
• 071B4Z4 Bypass Mesenteric Lymphatic to Central Vein, Percutaneous Endoscopic Approach
• 071B4Z7 Bypass Mesenteric Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
• 071B4ZK Bypass Mesenteric Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
• 071B4ZL Bypass Mesenteric Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
• 071C0Z3 Bypass Pelvis Lymphatic to Peripheral Vein, Open Approach
• 071C0Z4 Bypass Pelvis Lymphatic to Central Vein, Open Approach
• 071C0Z7 Bypass Pelvis Lymphatic to Lymphatic, Open Approach
• 071C0ZK Bypass Pelvis Lymphatic to Thoracic Duct, Open Approach
• 071C0ZL Bypass Pelvis Lymphatic to Cisterna Chyli, Open Approach
• 071C4Z3 Bypass Pelvis Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
• 071C4Z4 Bypass Pelvis Lymphatic to Central Vein, Percutaneous Endoscopic Approach
• 071C4Z7 Bypass Pelvis Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
• 071C4ZK Bypass Pelvis Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
• 071C4ZL Bypass Pelvis Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
• 071D0Z3 Bypass Aortic Lymphatic to Peripheral Vein, Open Approach
• 071D0Z4 Bypass Aortic Lymphatic to Central Vein, Open Approach
• 071D0Z7 Bypass Aortic Lymphatic to Lymphatic, Open Approach
• 071D0ZK Bypass Aortic Lymphatic to Thoracic Duct, Open Approach
• 071D0ZL Bypass Aortic Lymphatic to Cisterna Chyli, Open Approach
• 071D4Z3 Bypass Aortic Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
• 071D4Z4 Bypass Aortic Lymphatic to Central Vein, Percutaneous Endoscopic Approach
• 071D4Z7 Bypass Aortic Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
• 071D4ZK Bypass Aortic Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
• 071D4ZL Bypass Aortic Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
• 071F0Z3 Bypass Right Lower Extremity Lymphatic to Peripheral Vein, Open Approach
• 071F0Z4 Bypass Right Lower Extremity Lymphatic to Central Vein, Open Approach
• 071F0Z7 Bypass Right Lower Extremity Lymphatic to Lymphatic, Open Approach
• 071F0ZK Bypass Right Lower Extremity Lymphatic to Thoracic Duct, Open Approach
• 071F0ZL Bypass Right Lower Extremity Lymphatic to Cisterna Chyli, Open Approach
• 071F4Z3 Bypass Right Lower Extremity Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
• 071F4Z4 Bypass Right Lower Extremity Lymphatic to Central Vein, Percutaneous Endoscopic Approach
• 071F4Z7 Bypass Right Lower Extremity Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
• 071F4ZK Bypass Right Lower Extremity Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
• 071F4ZL Bypass Right Lower Extremity Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
• 071G0Z3 Bypass Left Lower Extremity Lymphatic to Peripheral Vein, Open Approach
• 071G0Z4 Bypass Left Lower Extremity Lymphatic to Central Vein, Open Approach
• 071G0Z7 Bypass Left Lower Extremity Lymphatic to Lymphatic, Open Approach
• 071G0ZK Bypass Left Lower Extremity Lymphatic to Thoracic Duct, Open Approach
• 071G0ZL Bypass Left Lower Extremity Lymphatic to Cisterna Chyli, Open Approach
• 071G4Z3 Bypass Left Lower Extremity Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
• 071G4Z4 Bypass Left Lower Extremity Lymphatic to Central Vein, Percutaneous Endoscopic Approach
• 071G4Z7 Bypass Left Lower Extremity Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
• 071G4ZK Bypass Left Lower Extremity Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
• 071G4ZL Bypass Left Lower Extremity Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
• 071H0Z3 Bypass Right Inguinal Lymphatic to Peripheral Vein, Open Approach
• 071H0Z4 Bypass Right Inguinal Lymphatic to Central Vein, Open Approach
• 071H0Z7 Bypass Right Inguinal Lymphatic to Lymphatic, Open Approach
• 071H0ZK Bypass Right Inguinal Lymphatic to Thoracic Duct, Open Approach
• 071H0ZL Bypass Right Inguinal Lymphatic to Cisterna Chyli, Open Approach
• 071H4Z3 Bypass Right Inguinal Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
• 071H4Z4 Bypass Right Inguinal Lymphatic to Central Vein, Percutaneous Endoscopic Approach
• 071H4Z7 Bypass Right Inguinal Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
• 071H4ZK Bypass Right Inguinal Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
• 071H4ZL Bypass Right Inguinal Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
• 071J0Z3 Bypass Left Inguinal Lymphatic to Peripheral Vein, Open Approach
• 071J0Z4 Bypass Left Inguinal Lymphatic to Central Vein, Open Approach
• 071J0Z7 Bypass Left Inguinal Lymphatic to Lymphatic, Open Approach
• 071J0ZK Bypass Left Inguinal Lymphatic to Thoracic Duct, Open Approach
• 071J0ZL Bypass Left Inguinal Lymphatic to Cisterna Chyli, Open Approach
• 071J4Z3 Bypass Left Inguinal Lymphatic to Peripheral Vein, Percutaneous Endoscopic Approach
• 071J4Z4 Bypass Left Inguinal Lymphatic to Central Vein, Percutaneous Endoscopic Approach
• 071J4Z7 Bypass Left Inguinal Lymphatic to Lymphatic, Percutaneous Endoscopic Approach
• 071J4ZK Bypass Left Inguinal Lymphatic to Thoracic Duct, Percutaneous Endoscopic Approach
• 071J4ZL Bypass Left Inguinal Lymphatic to Cisterna Chyli, Percutaneous Endoscopic Approach
• 071K0Z3 Bypass Thoracic Duct to Peripheral Vein, Open Approach
• 071K0Z4 Bypass Thoracic Duct to Central Vein, Open Approach
• 071K0Z7 Bypass Thoracic Duct to Lymphatic, Open Approach
• 071K0ZK Bypass Thoracic Duct to Thoracic Duct, Open Approach
• 071K0ZL Bypass Thoracic Duct to Cisterna Chyli, Open Approach
• 071K4Z3 Bypass Thoracic Duct to Peripheral Vein, Percutaneous Endoscopic Approach
• 071K4Z4 Bypass Thoracic Duct to Central Vein, Percutaneous Endoscopic Approach
• 071K4Z7 Bypass Thoracic Duct to Lymphatic, Percutaneous Endoscopic Approach
• 071K4ZK Bypass Thoracic Duct to Thoracic Duct, Percutaneous Endoscopic Approach
• 071K4ZL Bypass Thoracic Duct to Cisterna Chyli, Percutaneous Endoscopic Approach
• 071L0Z3 Bypass Cisterna Chyli to Peripheral Vein, Open Approach
• 071L0Z4 Bypass Cisterna Chyli to Central Vein, Open Approach
• 071L0Z7 Bypass Cisterna Chyli to Lymphatic, Open Approach
• 071L0ZK Bypass Cisterna Chyli to Thoracic Duct, Open Approach
• 071L0ZL Bypass Cisterna Chyli to Cisterna Chyli, Open Approach
• 071L4Z3 Bypass Cisterna Chyli to Peripheral Vein, Percutaneous Endoscopic Approach
• 071L4Z4 Bypass Cisterna Chyli to Central Vein, Percutaneous Endoscopic Approach
• 071L4Z7 Bypass Cisterna Chyli to Lymphatic, Percutaneous Endoscopic Approach
• 071L4ZK Bypass Cisterna Chyli to Thoracic Duct, Percutaneous Endoscopic Approach
• 071L4ZL Bypass Cisterna Chyli to Cisterna Chyli, Percutaneous Endoscopic Approach
• 0FP480Z Removal of Drainage Device from Gallbladder, Via Natural or Artificial Opening Endoscopic
• 0FPG80Z Removal of Drainage Device from Pancreas, Via Natural or Artificial Opening Endoscopic
• 0FW480Z Revision of Drainage Device in Gallbladder, Via Natural or Artificial Opening Endoscopic
• 0FWG80Z Revision of Drainage Device in Pancreas, Via Natural or Artificial Opening Endoscopic
• 0HRT07B Replacement of Right Breast using Lumbar Artery Perforator Flap, Open Approach
• 0HRU07B Replacement of Left Breast using Lumbar Artery Perforator Flap, Open Approach
• 0HRV07B Replacement of Bilateral Breast using Lumbar Artery Perforator Flap, Open Approach
• 0NPB05Z Removal of External Fixation Device from Nasal Bone, Open Approach
• 0NPB35Z Removal of External Fixation Device from Nasal Bone, Percutaneous Approach
• 0NPB45Z Removal of External Fixation Device from Nasal Bone, Percutaneous Endoscopic Approach
• 0NPBX5Z Removal of External Fixation Device from Nasal Bone, External Approach
• 0NPW05Z Removal of External Fixation Device from Facial Bone, Open Approach
• 0NPW35Z Removal of External Fixation Device from Facial Bone, Percutaneous Approach
• 0NPW45Z Removal of External Fixation Device from Facial Bone, Percutaneous Endoscopic Approach
• 0NPWX5Z Removal of External Fixation Device from Facial Bone, External Approach
• 0NWB05Z Revision of External Fixation Device in Nasal Bone, Open Approach
• 0NWB35Z Revision of External Fixation Device in Nasal Bone, Percutaneous Approach
• 0NWB45Z Revision of External Fixation Device in Nasal Bone, Percutaneous Endoscopic Approach
• 0NWBX5Z Revision of External Fixation Device in Nasal Bone, External Approach
• 0NWW05Z Revision of External Fixation Device in Facial Bone, Open Approach
• 0NWW35Z Revision of External Fixation Device in Facial Bone, Percutaneous Approach
• 0NWW45Z Revision of External Fixation Device in Facial Bone, Percutaneous Endoscopic Approach
• 0NWWX5Z Revision of External Fixation Device in Facial Bone, External Approach
• 5A05A0L Extracorporeal Peripheral Veno-venous Filtration, Intraoperative
• 8E023FZ Fiber Optic 3D Guided Procedure of Circulatory System, Percutaneous Approach
• X05133A Destruction of Renal Sympathetic Nerve(s) using Radiofrequency Ablation, Percutaneous Approach, New Technology Group 10
• X27P3TA Dilation of Right Anterior Tibial Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10
• X27Q3TA Dilation of Left Anterior Tibial Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10
• X27R3TA Dilation of Right Posterior Tibial Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10
• X27S3TA Dilation of Left Posterior Tibial Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10
• X27T3TA Dilation of Right Peroneal Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10
• X27U3TA Dilation of Left Peroneal Artery with Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s), Percutaneous Approach, New Technology Group 10
• X28F3VA Division of Aortic Valve using Intraluminal Bioprosthetic Valve Leaflet Splitting Technology in Existing Valve, Percutaneous Approach, New Technology Group 10
• X2R50WA Replacement of Right Upper Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10
• X2R60WA Replacement of Left Upper Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10
• X2R70WA Replacement of Right Lower Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10
• X2R80WA Replacement of Left Lower Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10
• X2RJ3RA Replacement of Tricuspid Valve with Multi-plane Flex Technology Bioprosthetic Valve, Percutaneous Approach, New Technology Group 10
• X2VE3SA Restriction of Descending Thoracic Aorta and Abdominal Aorta using Branched Intraluminal Device, Manufactured Integrated System, Four or More Arteries, Percutaneous Approach, New Technology Group 10
• XHR0XGA Replacement of Head and Neck Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
• XHR1XGA Replacement of Chest Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
• XHR2XGA Replacement of Abdomen Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
• XHR3XGA Replacement of Back Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
• XHR4XGA Replacement of Right Upper Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
• XHR5XGA Replacement of Left Upper Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
• XHR6XGA Replacement of Right Lower Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
• XHR7XGA Replacement of Left Lower Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
• XRGA0EA Fusion of Thoracolumbar Vertebral Joint using Facet Joint Fusion Device, Paired Titanium Cages, Open Approach, New Technology Group 10
• XRGB0EA Fusion of Lumbar Vertebral Joint using Facet Joint Fusion Device, Paired Titanium Cages, Open Approach, New Technology Group 10
• XRGC0EA Fusion of 2 or more Lumbar Vertebral Joints using Facet Joint Fusion Device, Paired Titanium Cages, Open Approach, New Technology Group 10
• XRGD0EA Fusion of Lumbosacral Joint using Facet Joint Fusion Device, Paired Titanium Cages, Open Approach, New Technology Group 10
• XRGJ0CA Fusion of Right Ankle Joint using Gyroid-Sheet Lattice Design Internal Fixation Device, Open Approach, New Technology Group 10
• XRGK0CA Fusion of Left Ankle Joint using Gyroid-Sheet Lattice Design Internal Fixation Device, Open Approach, New Technology Group 10
• XRGL0CA Fusion of Right Tarsal Joint using Gyroid-Sheet Lattice Design Internal Fixation Device, Open Approach, New Technology Group 10
• XRGM0CA Fusion of Left Tarsal Joint using Gyroid-Sheet Lattice Design Internal Fixation Device, Open Approach, New Technology Group 10
• XRH60FA Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Thoracic Vertebral Joint, Open Approach, New Technology Group 10
• XRH63FA Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Thoracic Vertebral Joint, Percutaneous Approach, New Technology Group 10
• XRH64FA Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Thoracic Vertebral Joint, Percutaneous Endoscopic Approach, New Technology Group 10
• XRH70FA Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 2 to 7 Thoracic Vertebral Joints, Open Approach, New Technology Group 10
• XRH73FA Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 2 to 7 Thoracic Vertebral Joints, Percutaneous Approach, New Technology Group 10
• XRH74FA Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 2 to 7 Thoracic Vertebral Joints, Percutaneous Endoscopic Approach, New Technology Group 10
• XRH80FA Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 8 or more Thoracic Vertebral Joints, Open Approach, New Technology Group 10
• XRH83FA Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 8 or more Thoracic Vertebral Joints, Percutaneous Approach, New Technology Group 10
• XRH84FA Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 8 or more Thoracic Vertebral Joints, Percutaneous Endoscopic Approach, New Technology Group 10
• XRHA0FA Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Thoracolumbar Vertebral Joint, Open Approach, New Technology Group 10
• XRHA3FA Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Thoracolumbar Vertebral Joint, Percutaneous Approach, New Technology Group 10
• XRHA4FA Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Thoracolumbar Vertebral Joint, Percutaneous Endoscopic Approach, New Technology Group 10
• XRHB0FA Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Lumbar Vertebral Joint, Open Approach, New Technology Group 10
• XRHB3FA Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Lumbar Vertebral Joint, Percutaneous Approach, New Technology Group 10
• XRHB4FA Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Lumbar Vertebral Joint, Percutaneous Endoscopic Approach, New Technology Group 10
• XRHC0FA Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 2 or more Lumbar Vertebral Joints, Open Approach, New Technology Group 10
• XRHC3FA Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 2 or more Lumbar Vertebral Joints, Percutaneous Approach, New Technology Group 10
• XRHC4FA Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into 2 or more Lumbar Vertebral Joints, Percutaneous Endoscopic Approach, New Technology Group 10
• XRHD0FA Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Lumbosacral Joint, Open Approach, New Technology Group 10
• XRHD3FA Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Lumbosacral Joint, Percutaneous Approach, New Technology Group 10
• XRHD4FA Insertion of Pedicle Based Carbon/PEEK Spinal Stabilization Device into Lumbosacral Joint, Percutaneous Endoscopic Approach, New Technology Group 10
• XW0136A Introduction of Dasiglucagon into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 10
• XW0333A Introduction of Bentracimab, Ticagrelor Reversal Agent into Peripheral Vein, Percutaneous Approach, New Technology Group 10
• XW0334A Introduction of Cefepime-taniborbactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 10
• XW0335A Introduction of Ceftobiprole Medocaril Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 10
• XW0338A Introduction of Obecabtagene Autoleucel into Peripheral Vein, Percutaneous Approach, New Technology Group 10
• XW0339A Introduction of Odronextamab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 10
• XW033BA Introduction of Orca-T Allogeneic T-cell Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 10
• XW033CA Introduction of Zanidatamab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 10
• XW033DA Introduction of Donislecel-jujn Allogeneic Pancreatic Islet Cellular Suspension into Peripheral Vein, Percutaneous Approach, New Technology Group 10
• XW033FA Introduction of Non-Chimeric Antigen Receptor T-cell Immune Effector Cell Therapy into Peripheral Vein, Percutaneous Approach, New Technology Group 10
• XW0433A Introduction of Bentracimab, Ticagrelor Reversal Agent into Central Vein, Percutaneous Approach, New Technology Group 10
• XW0434A Introduction of Cefepime-taniborbactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 10
• XW0435A Introduction of Ceftobiprole Medocaril Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 10
• XW0438A Introduction of Obecabtagene Autoleucel into Central Vein, Percutaneous Approach, New Technology Group 10
• XW0439A Introduction of Odronextamab Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 10
• XW043BA Introduction of Orca-T Allogeneic T-cell Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 10
• XW043CA Introduction of Zanidatamab Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 10
• XW043FA Introduction of Non-Chimeric Antigen Receptor T-cell Immune Effector Cell Therapy into Central Vein, Percutaneous Approach, New Technology Group 10
• XW0J3HA Introduction of Paclitaxel-Coated Balloon Technology, One Balloon into Coronary Artery, One Artery, Percutaneous Approach, New Technology Group 10
• XW0J3JA Introduction of Paclitaxel-Coated Balloon Technology, Two Balloons into Coronary Artery, One Artery, Percutaneous Approach, New Technology Group 10
• XW0J3KA Introduction of Paclitaxel-Coated Balloon Technology, Three Balloons into Coronary Artery, One Artery, Percutaneous Approach, New Technology Group 10
• XW0J3LA Introduction of Paclitaxel-Coated Balloon Technology, Four or More Balloons into Coronary Artery, One Artery, Percutaneous Approach, New Technology Group 10
• XW0K3HA Introduction of Paclitaxel-Coated Balloon Technology, One Balloon into Coronary Artery, Two Arteries, Percutaneous Approach, New Technology Group 10
• XW0K3JA Introduction of Paclitaxel-Coated Balloon Technology, Two Balloons into Coronary Artery, Two Arteries, Percutaneous Approach, New Technology Group 10
• XW0K3KA Introduction of Paclitaxel-Coated Balloon Technology, Three Balloons into Coronary Artery, Two Arteries, Percutaneous Approach, New Technology Group 10
• XW0K3LA Introduction of Paclitaxel-Coated Balloon Technology, Four or More Balloons into Coronary Artery, Two Arteries, Percutaneous Approach, New Technology Group 10
• XW0L3HA Introduction of Paclitaxel-Coated Balloon Technology, One Balloon into Coronary Artery, Three Arteries, Percutaneous Approach, New Technology Group 10
• XW0L3JA Introduction of Paclitaxel-Coated Balloon Technology, Two Balloons into Coronary Artery, Three Arteries, Percutaneous Approach, New Technology Group 10
• XW0L3KA Introduction of Paclitaxel-Coated Balloon Technology, Three Balloons into Coronary Artery, Three Arteries, Percutaneous Approach, New Technology Group 10
• XW0L3LA Introduction of Paclitaxel-Coated Balloon Technology, Four or More Balloons into Coronary Artery, Three Arteries, Percutaneous Approach, New Technology Group 10
• XW0M3HA Introduction of Paclitaxel-Coated Balloon Technology, One Balloon into Coronary Artery, Four or More Arteries, Percutaneous Approach, New Technology Group 10
• XW0M3JA Introduction of Paclitaxel-Coated Balloon Technology, Two Balloons into Coronary Artery, Four or More Arteries, Percutaneous Approach, New Technology Group 10
• XW0M3KA Introduction of Paclitaxel-Coated Balloon Technology, Three Balloons into Coronary Artery, Four or More Arteries, Percutaneous Approach, New Technology Group 10
• XW0M3LA Introduction of Paclitaxel-Coated Balloon Technology, Four or More Balloons into Coronary Artery, Four or More Arteries, Percutaneous Approach, New Technology Group 10
• XW0U0GA Introduction of Vancomycin Hydrochloride and Tobramycin Sulfate Anti-Infective, Temporary Irrigation Spacer System into Joints, Open Approach, New Technology Group 10
• XW0V3WA Introduction of AGN1 Bone Void Filler into Bones, Percutaneous Approach, New Technology Group 10
• XW1337A Transfusion of Marnetegragene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 10
• XW1437A Transfusion of Marnetegragene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 10
• XX25X0A Monitoring of Blood Flow, Adhesive Ultrasound Patch Technology, New Technology Group 10
• XXA536A Circulatory Filtration, Blood Pathogens, Percutaneous Approach, New Technology Group 10
• XXE0X1A Measurement of Intracranial Cerebrospinal Fluid Flow, Computer-aided Triage and Notification, New Technology Group 10
• XXE5X2A Measurement of Infection, Phenotypic Fully Automated Rapid Susceptibility Technology with Controlled Inoculum, New Technology Group 10
• XXE5X4A Measurement of Infection, Positive Blood Culture Small Molecule Sensor Array Technology, New Technology Group 10

Deleted codes (61)

• X27H385 Dilation of Right Femoral Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
• X27H395 Dilation of Right Femoral Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27H3B5 Dilation of Right Femoral Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27H3C5 Dilation of Right Femoral Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27J385 Dilation of Left Femoral Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
• X27J395 Dilation of Left Femoral Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27J3B5 Dilation of Left Femoral Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27J3C5 Dilation of Left Femoral Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27K385 Dilation of Proximal Right Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
• X27K395 Dilation of Proximal Right Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27K3B5 Dilation of Proximal Right Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27K3C5 Dilation of Proximal Right Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27L385 Dilation of Proximal Left Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
• X27L395 Dilation of Proximal Left Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27L3B5 Dilation of Proximal Left Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27L3C5 Dilation of Proximal Left Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27M385 Dilation of Distal Right Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
• X27M395 Dilation of Distal Right Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27M3B5 Dilation of Distal Right Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27M3C5 Dilation of Distal Right Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27N385 Dilation of Distal Left Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
• X27N395 Dilation of Distal Left Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27N3B5 Dilation of Distal Left Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27N3C5 Dilation of Distal Left Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27P385 Dilation of Right Anterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
• X27P395 Dilation of Right Anterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27P3B5 Dilation of Right Anterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27P3C5 Dilation of Right Anterior Tibial Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27Q385 Dilation of Left Anterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
• X27Q395 Dilation of Left Anterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27Q3B5 Dilation of Left Anterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27Q3C5 Dilation of Left Anterior Tibial Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27R385 Dilation of Right Posterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
• X27R395 Dilation of Right Posterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27R3B5 Dilation of Right Posterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27R3C5 Dilation of Right Posterior Tibial Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27S385 Dilation of Left Posterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
• X27S395 Dilation of Left Posterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27S3B5 Dilation of Left Posterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27S3C5 Dilation of Left Posterior Tibial Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27T385 Dilation of Right Peroneal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
• X27T395 Dilation of Right Peroneal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27T3B5 Dilation of Right Peroneal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27T3C5 Dilation of Right Peroneal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27U385 Dilation of Left Peroneal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5
• X27U395 Dilation of Left Peroneal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27U3B5 Dilation of Left Peroneal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• X27U3C5 Dilation of Left Peroneal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5
• XW033K5 Introduction of Fosfomycin Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 5
• XW033N5 Introduction of Meropenem-vaborbactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 5
• XW033U5 Introduction of Imipenem-cilastatin-relebactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 5
• XW043K5 Introduction of Fosfomycin Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 5
• XW043N5 Introduction of Meropenem-vaborbactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 5
• XW043U5 Introduction of Imipenem-cilastatin-relebactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 5
• XW097M5 Introduction of Esketamine Hydrochloride into Nose, Via Natural or Artificial Opening, New Technology Group 5
• XW0DXJ5 Introduction of Apalutamide Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5
• XW0DXL5 Introduction of Erdafitinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5
• XW0DXR5 Introduction of Venetoclax Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5
• XW0DXT5 Introduction of Ruxolitinib into Mouth and Pharynx, External Approach, New Technology Group 5
• XW0DXV5 Introduction of Gilteritinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5
• XXE5XM5 Measurement of Infection, Whole Blood Nucleic Acid-base Microbial Detection, New Technology Group 5